Incidence of thrombotic complications in hospitalised and non‐hospitalised patients after COVID‐19 diagnosis

Infection with coronavirus disease‐2019 (COVID‐19) may predispose for venous thromboembolism (VTE). There is wide variation in reported incidence rates of VTE in COVID‐19, ranging from 3% to 85%. Therefore, the true incidence of thrombotic complications in COVID‐19 is uncertain. Here we present data...

Descripción completa

Detalles Bibliográficos
Autores principales: Tholin, Birgitte, Ghanima, Waleed, Einvik, Gunnar, Aarli, Bernt, Brønstad, Eivind, Skjønsberg, Ole H., Stavem, Knut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Covid‐19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239792/
https://www.ncbi.nlm.nih.gov/pubmed/34028814
http://dx.doi.org/10.1111/bjh.17522
_version_ 1783715111765016576
author Tholin, Birgitte
Ghanima, Waleed
Einvik, Gunnar
Aarli, Bernt
Brønstad, Eivind
Skjønsberg, Ole H.
Stavem, Knut
author_facet Tholin, Birgitte
Ghanima, Waleed
Einvik, Gunnar
Aarli, Bernt
Brønstad, Eivind
Skjønsberg, Ole H.
Stavem, Knut
author_sort Tholin, Birgitte
collection PubMed
description Infection with coronavirus disease‐2019 (COVID‐19) may predispose for venous thromboembolism (VTE). There is wide variation in reported incidence rates of VTE in COVID‐19, ranging from 3% to 85%. Therefore, the true incidence of thrombotic complications in COVID‐19 is uncertain. Here we present data on the incidence of VTE in both hospitalised and non‐hospitalised patients from two ongoing prospective cohort studies. The incidence of VTE after diagnosis of COVID‐19 was 3·9% [95% confidence interval (CI): 2·1–7·2] during hospitalisation, 0·9% (95% CI: 0·2–3·1) in the three months after discharge and 0·2% (95% CI: 0·00–1·25) in non‐hospitalised patients, suggesting an incidence rate at the lower end of that in previous reports.
format Online
Article
Text
id pubmed-8239792
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82397922021-06-29 Incidence of thrombotic complications in hospitalised and non‐hospitalised patients after COVID‐19 diagnosis Tholin, Birgitte Ghanima, Waleed Einvik, Gunnar Aarli, Bernt Brønstad, Eivind Skjønsberg, Ole H. Stavem, Knut Br J Haematol Covid‐19 Infection with coronavirus disease‐2019 (COVID‐19) may predispose for venous thromboembolism (VTE). There is wide variation in reported incidence rates of VTE in COVID‐19, ranging from 3% to 85%. Therefore, the true incidence of thrombotic complications in COVID‐19 is uncertain. Here we present data on the incidence of VTE in both hospitalised and non‐hospitalised patients from two ongoing prospective cohort studies. The incidence of VTE after diagnosis of COVID‐19 was 3·9% [95% confidence interval (CI): 2·1–7·2] during hospitalisation, 0·9% (95% CI: 0·2–3·1) in the three months after discharge and 0·2% (95% CI: 0·00–1·25) in non‐hospitalised patients, suggesting an incidence rate at the lower end of that in previous reports. John Wiley and Sons Inc. 2021-05-24 2021-08 /pmc/articles/PMC8239792/ /pubmed/34028814 http://dx.doi.org/10.1111/bjh.17522 Text en © 2021 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Covid‐19
Tholin, Birgitte
Ghanima, Waleed
Einvik, Gunnar
Aarli, Bernt
Brønstad, Eivind
Skjønsberg, Ole H.
Stavem, Knut
Incidence of thrombotic complications in hospitalised and non‐hospitalised patients after COVID‐19 diagnosis
title Incidence of thrombotic complications in hospitalised and non‐hospitalised patients after COVID‐19 diagnosis
title_full Incidence of thrombotic complications in hospitalised and non‐hospitalised patients after COVID‐19 diagnosis
title_fullStr Incidence of thrombotic complications in hospitalised and non‐hospitalised patients after COVID‐19 diagnosis
title_full_unstemmed Incidence of thrombotic complications in hospitalised and non‐hospitalised patients after COVID‐19 diagnosis
title_short Incidence of thrombotic complications in hospitalised and non‐hospitalised patients after COVID‐19 diagnosis
title_sort incidence of thrombotic complications in hospitalised and non‐hospitalised patients after covid‐19 diagnosis
topic Covid‐19
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239792/
https://www.ncbi.nlm.nih.gov/pubmed/34028814
http://dx.doi.org/10.1111/bjh.17522
work_keys_str_mv AT tholinbirgitte incidenceofthromboticcomplicationsinhospitalisedandnonhospitalisedpatientsaftercovid19diagnosis
AT ghanimawaleed incidenceofthromboticcomplicationsinhospitalisedandnonhospitalisedpatientsaftercovid19diagnosis
AT einvikgunnar incidenceofthromboticcomplicationsinhospitalisedandnonhospitalisedpatientsaftercovid19diagnosis
AT aarlibernt incidenceofthromboticcomplicationsinhospitalisedandnonhospitalisedpatientsaftercovid19diagnosis
AT brønstadeivind incidenceofthromboticcomplicationsinhospitalisedandnonhospitalisedpatientsaftercovid19diagnosis
AT skjønsbergoleh incidenceofthromboticcomplicationsinhospitalisedandnonhospitalisedpatientsaftercovid19diagnosis
AT stavemknut incidenceofthromboticcomplicationsinhospitalisedandnonhospitalisedpatientsaftercovid19diagnosis

Ejemplares similares